Report Detail

Other Global Antithrombin Market Insights, Forecast to 2025

  • RnM2455581
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Other

Antithrombin (AT) is a small protein molecule that inactivates several enzymes of the coagulation system. Antithrombin is a glycoprotein produced by the liver and consists of 432 amino acids. It contains three disulfide bonds and a total of four possible glycosylation sites. α-Antithrombin is the dominant form of antithrombin found in blood plasma and has an oligosaccharide occupying each of its four glycosylation sites.
Antithrombin I (AT I) refers to the absorption of thrombin onto fibrin after thrombin has activated fibrinogen. Antithrombin II (AT II) refers to a cofactor in plasma, which together with heparin interferes with the interaction of thrombin and fibrinogen. Antithrombin III (AT III) refers to a substance in plasma that inactivates thrombin. Antithrombin IV (AT IV) refers to an antithrombin that becomes activated during and shortly after blood coagulation.Only AT III and possibly AT I are medically significant. AT III is generally referred to solely as "Antithrombin" and it is Antithrombin III that is discussed in this article.
Global Antithrombin market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antithrombin.

This report researches the worldwide Antithrombin market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Antithrombin breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Grifols
rEVO Biologics Inc.
Shire plc
Kedrion S.p.A.
CSL Limited
Scripps Laboratories Inc.
Lee Biosolutions

Antithrombin Breakdown Data by Type
Liquid
Lyophilized
Antithrombin Breakdown Data by Application
Diagnostics
Therapeutics
Research

Antithrombin Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Antithrombin Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Antithrombin capacity, production, value, consumption, status and forecast;
To focus on the key Antithrombin manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antithrombin :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    Global Antithrombin Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Antithrombin Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Antithrombin Market Size Growth Rate by Type
        • 1.4.2 Liquid
        • 1.4.3 Lyophilized
      • 1.5 Market by Application
        • 1.5.1 Global Antithrombin Market Size Growth Rate by Application
        • 1.5.2 Diagnostics
        • 1.5.3 Therapeutics
        • 1.5.4 Research
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Antithrombin Production
        • 2.1.1 Global Antithrombin Revenue 2014-2025
        • 2.1.2 Global Antithrombin Production 2014-2025
        • 2.1.3 Global Antithrombin Capacity 2014-2025
        • 2.1.4 Global Antithrombin Marketing Pricing and Trends
      • 2.2 Antithrombin Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Antithrombin Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Antithrombin Production by Manufacturers
        • 3.1.1 Antithrombin Production by Manufacturers
        • 3.1.2 Antithrombin Production Market Share by Manufacturers
      • 3.2 Antithrombin Revenue by Manufacturers
        • 3.2.1 Antithrombin Revenue by Manufacturers (2014-2019)
        • 3.2.2 Antithrombin Revenue Share by Manufacturers (2014-2019)
      • 3.3 Antithrombin Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Antithrombin Production by Regions

      • 4.1 Global Antithrombin Production by Regions
        • 4.1.1 Global Antithrombin Production Market Share by Regions
        • 4.1.2 Global Antithrombin Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Antithrombin Production
        • 4.2.2 United States Antithrombin Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Antithrombin Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Antithrombin Production
        • 4.3.2 Europe Antithrombin Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Antithrombin Import & Export
      • 4.4 China
        • 4.4.1 China Antithrombin Production
        • 4.4.2 China Antithrombin Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Antithrombin Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Antithrombin Production
        • 4.5.2 Japan Antithrombin Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Antithrombin Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Antithrombin Consumption by Regions

      • 5.1 Global Antithrombin Consumption by Regions
        • 5.1.1 Global Antithrombin Consumption by Regions
        • 5.1.2 Global Antithrombin Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Antithrombin Consumption by Application
        • 5.2.2 North America Antithrombin Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Antithrombin Consumption by Application
        • 5.3.2 Europe Antithrombin Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Antithrombin Consumption by Application
        • 5.4.2 Asia Pacific Antithrombin Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Antithrombin Consumption by Application
        • 5.5.2 Central & South America Antithrombin Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Antithrombin Consumption by Application
        • 5.6.2 Middle East and Africa Antithrombin Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Antithrombin Breakdown Dada by Type
      • 6.2 Global Antithrombin Revenue by Type
      • 6.3 Antithrombin Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Antithrombin Breakdown Dada by Application
        • 7.2.1 Global Antithrombin Consumption by Application
        • 7.2.2 Global Antithrombin Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Grifols
        • 8.1.1 Grifols Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Antithrombin
        • 8.1.4 Antithrombin Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 rEVO Biologics Inc.
        • 8.2.1 rEVO Biologics Inc. Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Antithrombin
        • 8.2.4 Antithrombin Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Shire plc
        • 8.3.1 Shire plc Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Antithrombin
        • 8.3.4 Antithrombin Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Kedrion S.p.A.
        • 8.4.1 Kedrion S.p.A. Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Antithrombin
        • 8.4.4 Antithrombin Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 CSL Limited
        • 8.5.1 CSL Limited Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Antithrombin
        • 8.5.4 Antithrombin Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Scripps Laboratories Inc.
        • 8.6.1 Scripps Laboratories Inc. Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Antithrombin
        • 8.6.4 Antithrombin Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Lee Biosolutions
        • 8.7.1 Lee Biosolutions Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Antithrombin
        • 8.7.4 Antithrombin Product Description
        • 8.7.5 SWOT Analysis

      9 Production Forecasts

      • 9.1 Antithrombin Production and Revenue Forecast
        • 9.1.1 Global Antithrombin Production Forecast 2019-2025
        • 9.1.2 Global Antithrombin Revenue Forecast 2019-2025
      • 9.2 Antithrombin Production and Revenue Forecast by Regions
        • 9.2.1 Global Antithrombin Revenue Forecast by Regions
        • 9.2.2 Global Antithrombin Production Forecast by Regions
      • 9.3 Antithrombin Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Antithrombin Production Forecast by Type
        • 9.4.2 Global Antithrombin Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Antithrombin Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Antithrombin Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Antithrombin Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Antithrombin Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Antithrombin Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Antithrombin Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Antithrombin Upstream Market
        • 11.1.1 Antithrombin Key Raw Material
        • 11.1.2 Typical Suppliers of Key Antithrombin Raw Material
        • 11.1.3 Antithrombin Raw Material Market Concentration Rate
      • 11.2 Antithrombin Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Antithrombin Distributors
      • 11.5 Antithrombin Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Summary:
        Get latest Market Research Reports on Antithrombin . Industry analysis & Market Report on Antithrombin is a syndicated market report, published as Global Antithrombin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antithrombin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,900.00
        $5,850.00
        $7,800.00
        3,112.20
        4,668.30
        6,224.40
        3,642.60
        5,463.90
        7,285.20
        609,453.00
        914,179.50
        1,218,906.00
        325,611.00
        488,416.50
        651,222.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report